News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

PressDigest

Teva weighs Mylan bid to disrupt Perrigo deal

Teva Pharmaceutical Industries, the Israeli generic drug maker, is weighing a takeover offer for rival Mylan to thwart the latter’s proposed $28.9bn acquisition of Ireland-based Perrigo, The Wall Street Journal has learnt.

WSJ Logo